Standard of care chemotherapy
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Standard of care chemotherapy, covering 2024-06-26 to 2025-09-18. Get the full timeline:
Most recent: Clinical Trial Update: Study of Nivolumab in Combination With Ipilimumab or Standard of Care Chemotherapy Compared to the Standard of Care Chemotherapy Alone in Treatment of Participants With Untreated Inoperable or Metastatic Urothelial Cancer [Phase 3]